Carl Dambkowski Sells 7,335 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) Stock

Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) insider Carl Dambkowski sold 7,335 shares of Apogee Therapeutics stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $40.67, for a total value of $298,314.45. Following the sale, the insider now directly owns 287,458 shares in the company, valued […]

Leave a Reply

Your email address will not be published.

Previous post Investment app Gather collapses after failing to repay government loan
Next post Newell Brands Inc. (NASDAQ:NWL) Receives $8.82 Consensus Price Target from Analysts